Indonesia Suspends use of AstraZeneca Vaccine
In Indonesia, the government suspended the use of that batch of vaccines as a person died after receiving the Covid-19 vaccine developed by AstraZeneca.
While the vaccination campaign against the Covid-19 outbreak continues worldwide, Indonesia has made a new decision regarding the use of the Covid-19 vaccine developed by AstraZeneca.
In Indonesia, it was reported that the distribution and use of that party of the vaccine was suspended after the death of a 22-year-old person who received the AstraZeneca vaccine on May 6.
In the statement made by the Indonesian Ministry of Health, the decision was described as a “precaution”, and it was stated that after the completion of the necessary safety procedures, the use of other vaccines provided so far will continue.
It was noted that the AstraZeneca production Covid-19 vaccine was administered from the party of approximately 450 doses received last month to the person who died, while the party in question was part of the 3 million 852 thousand doses guaranteed by the World Health Organization (WHO) supported COVAX formation.
In Indonesia, the corona virus epidemic has reached 1 million 739 thousand 750 so far, and the total loss of life has reached 48 thousand 93.